Testing the MRace implant for leaky heart valve repair
Part of Heart & circulation clinical trials.
This trial tests a new device called MRace that may fix a leaky mitral valve without open-heart surgery. It's for people whose valve leaks severely and who can't have standard surgery due to other health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- Your mitral valve leak must be severe (grade 3+), confirmed by an ultrasound within the last 3 months.
- Your surgical risk score must be low enough (under 10%), but you still can't have standard surgery because of things like calcium buildup in the valve.
- You should be in heart failure with symptoms like shortness of breath or fatigue even at rest or with light activity.
- You must be able to attend follow-up visits for at least 1 year.
- You cannot have other serious heart valve problems, blood clots, active infections, or recent strokes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device called the MRace implant that is designed to repair a leaky mitral valve without open-heart surgery. It may help people with severe leakage who are at high risk for traditional surgery.
This trial tests a new device to fix a leaky mitral valve in people with moderate to severe leakage who are too high-risk for open-heart surgery. It aims to improve heart function and symptoms.
This trial tests a new device, called MRace, that is placed with a thin tube into the heart to fix a leaky mitral valve. It's for people whose valve is too complex for the usual clip repair, and who are too high-risk for open-heart surgery.
This study tests a new device called MRace for people with a leaking mitral valve (functional mitral regurgitation) whose heart structure makes standard repair difficult. The device is placed through a vein in the leg to fix the leak without open-heart surgery.
This study tests a new device (MRace) for people with a leaky mitral valve whose anatomy is too complex for the standard clip treatment. The device is placed through a vein in the leg to help the valve close better, which may reduce symptoms and improve quality of life.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
Hear when a new Mitral Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.